Skip to main content
. 2022 Jul 28;57(11):848–866. doi: 10.1007/s00535-022-01902-7

Table 2.

Comparison of cohort characteristics

Median (1st quartile-3rd quartile); min–max SIBDCS CoLaus¦PsyCoLaus Pearson’s r (Pr)/Cramer’s V (CV) P value

Neuroticism

SIBDCS N = 1119 CoLaus¦PsyCoLaus N = 2535

19.0 (14.0–25.0); 0–46.0 18.0 (13.0–23.0); 0–45.0 Pr = 0.074 < 0.001

Extraversion

SIBDCS N = 1097

CoLaus¦PsyCoLaus N = 2535

27.0 (22.0–31.0); 1.0–43.0 28.0 (24.0–32.0); 3.0–45.0 Pr = 0.096 < 0.001

Opennessa

SIBDCS N = 1076

CoLaus¦PsyCoLaus N = 2471

23.0 (19.0–27.0); 5.0–40.0 21.0 (19.0–24.0); 7.0–33.0 Pr = 0.144 < 0.001

Agreeableness

SIBDCS N = 1083

CoLaus¦PsyCoLaus N = 2535

33.0 (29.0–36.0); 9.0–48.0 18.0 (30.0–37.0); 12.0–48.0 Pr = 0.063 < 0.001

Conscientiousness

SIBDCS N = 1098

CoLaus¦PsyCoLaus N = 2535

36.0 (32.0–40.0); 10.0–48.0 35.0 (32.0–39.0); 7.0–48.0 Pr = 0.028 0.096

NEO-FFI(-R) risk score

SIBDCS N = 1119

CoLaus¦PsyCoLaus N = 2473

11.2 (8.8–13.6); 0.0–24.5 11.1 (9.3–12.9); 2.6–22.1 Pr = 0.019 0.251

NEO-FFI(-R) risk groups

(Cut-off = 11.3)b SIBDCS N = 1119 CoLaus¦PsyCoLaus N = 2473

High risk 554/1119 (49.5%) 1148/2473 (46.4%) CV = 0.029 0.093

Type D personality SIBDCS N = 1101

CoLaus¦PsyCoLaus N = 2578

Yes 336/1101 (30.5%) 397/2578 (15.4%) CV = 0.173  < 0.001

Sex

SIBDCS N = 1119 CoLaus¦PsyCoLaus N = 2600

Male 534/1119 (47.7%) 1111/2600 (42.7%) CV = 0.046 0.006

Age (years)

SIBDCS: N = 1119

CoLaus¦PsyCoLaus: N = 2600

41.3 (31.0–52.6); 14.8–84.6 59.4 (41.5–67.6); 41.5–54.2 Pr = 0.515 < 0.001

BMI (kg/m2)

SIBDCS N = 1081

CoLaus¦PsyCoLaus N = 2544

23.2 (21.0–26.1); 14.7–55.1 25.4 (22.8–28.3); 15.8–44.8 Pr = 0.217 < 0.001
Smoking status SIBDCS N = 1110, CoLaus¦PsyCoLaus N = 2558 Smoker 312/1110 (28.1%) 507/2558 (19.8%) CV = 0.091 < 0.001
Daily alcohol consumption SIBDCS: N = 1103, CoLaus¦PsyCoLaus: N = 2573 Yes 88/1103 (8.0%) 726/2573 (28.2%) CV = 0.223 < 0.001

Academic education

SIBDCS N = 1091, CoLaus¦PsyCoLaus N = 2599

Yes 157/1091 (14.4%) 706/2599 (27.2%) CV = 0.138 < 0.001

Cohort characteristics of study participants from the SIBDCS at enrolment and the CoLaus¦PsyCoLaus cohort at NEO-FFI assessment. P values were calculated using the Mann–Whitney U or χ2 tests, respectively. Effect sizes were calculated as Pearson’s r or Cramer’s V, respectively. Numbers diverging from 1154 (SIBDCS) or 2600 (CoLaus¦PsyCoLaus), respectively, are due to missing data for certain variables

NEO-FFI NEO-five-factor inventory, SIBDCS swiss IBD cohort study

aNEO-FFI items 28 and 33 are missing because they were not assessed in the SIBDCS (compare limitations)

bThe cut-off value (11.3) to interpret NEO-FFI risk groups is the mean NEO-FFI risk score of all included SIBDCS patients (training and validation data)

Bold values indicate significant P-values (i.e. P < 0.05) or moderate-high correlations (i.e. Pr/CV > 0.500), respectively